Women's Cancer Research Foundation Welcomes New Board Member
Women's Cancer Research Foundation (WCRF) is pleased to announce our new Board Member, Jerry Burton.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Women's Cancer Research Foundation Welcomes New Board Member
Obesity and Cancer Death Among White and Black Adults
The Importance of Observation
Research Breakthrough Could Protect Against Breast Cancer Progression
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%
Oral Contraceptives May Reduce Risk of Ovarian Cancer in BRCA Carriers
Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab
Blood Test for Many Cancer Types as Supplement to Screening
Cognitive Function After Cancer and Cancer Treatment
Association Between Breastfeeding and Ovarian Cancer Risk
Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers
Drug Boosts Survival for Women with Advanced Ovarian Cancer
Sleep quality and related factors in patients with breast cancer: A cross- sectional study in Taiwan
Associations Between Multimorbidity and Depression in Breast Cancer Survivors